Hemangeol (Propranolol HCl) Patent Expiration, LOE Window & CMS Spending

Hemangeol (Propranolol HCl) by Eton: FDA Orange Book LOE 2028-10-16, 19 AB generics, $7.2M 2024 CMS Part D & Medicaid spend, and 1 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorEton
FDA Application & PathwayN205410 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2028-10-16
Orange Book Patents (*PED Extensions)2 patents (0 *PED)
Active AB-Rated Generic Competitors19
2024 CMS Total Public Spend$7.2M
2024 Medicare Part D Spend$0
2024 Medicaid Spend$7.2M
Reported Wholesale Price Change (CA SB 17)1 WAC filings (max 699.5% 2-yr change)